-+ 0.00%
-+ 0.00%
-+ 0.00%

CTT Pharmaceutical CEO Ryan Khouri acquires 3,700 common shares valued at $203.50

PUBT·10/06/2026 21:24:49
Listen to the news
CTT Pharmaceutical CEO Ryan Khouri acquires 3,700 common shares valued at $203.50
  • CTT Pharmaceutical Holdings reported an open-market purchase of 3,700 CTTH shares at $0.055 each.
  • Directly held stake rose to 9,433,656 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001035422-26-000016), on October 06, 2026, and is solely responsible for the information contained therein.